Abstract

Growing evidence supports the importance of the p53 tumor suppressor in metabolism but the mechanisms underlying p53-mediated control of metabolism remain poorly understood. Here, we identify the multifunctional E4F1 protein as a key regulator of p53 metabolic functions in adipocytes. While E4F1 expression is upregulated during obesity, E4f1 inactivation in mouse adipose tissue results in a lean phenotype associated with insulin resistance and protection against induced obesity. Adipocytes lacking E4F1 activate a p53-dependent transcriptional program involved in lipid metabolism. The direct interaction between E4F1 and p53 and their co-recruitment to the Steaoryl-CoA Desaturase-1 locus play an important role to regulate monounsaturated fatty acids synthesis in adipocytes. Consistent with the role of this E4F1-p53-Steaoryl-CoA Desaturase-1 axis in adipocytes, p53 inactivation or diet complementation with oleate partly restore adiposity and improve insulin sensitivity in E4F1-deficient mice. Altogether, our findings identify a crosstalk between E4F1 and p53 in the control of lipid metabolism in adipocytes that is relevant to obesity and insulin resistance.

The p53 tumor suppressor is also a regulator of metabolism, but the mechanisms controlling p53-associated metabolic activities remain poorly understood. Here the authors report that the deletion of the multifunctional protein E4F1 is protective against diet-induced obesity in mice, and E4F1 regulates adipocyte lipid metabolism through p53.

Details

Title
The multifunctional protein E4F1 links P53 to lipid metabolism in adipocytes
Author
Lacroix Matthieu 1   VIAFID ORCID Logo  ; Linares, Laetitia K 1 ; Rueda-Rincon, Natalia 2 ; Bloch Katarzyna 2 ; Di Michele Michela 1 ; De Blasio Carlo 1   VIAFID ORCID Logo  ; Fau, Caroline 1 ; Gayte Laurie 1 ; Blanchet Emilie 3 ; Mairal Aline 4 ; Derua Rita 5 ; Cardona, Fernando 6   VIAFID ORCID Logo  ; Beuzelin Diane 4 ; Jean-Sebastien, Annicotte 7   VIAFID ORCID Logo  ; Pirot Nelly 8 ; Torro Adeline 3 ; Tinahones, Francisco J 9 ; Bernex Florence 8 ; Bertrand-Michel, Justine 4 ; Langin Dominique 10   VIAFID ORCID Logo  ; Fajas Lluis 11   VIAFID ORCID Logo  ; Swinnen, Johannes V 2   VIAFID ORCID Logo  ; Le Cam Laurent 1   VIAFID ORCID Logo 

 IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Univ Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France (GRID:grid.488845.d) (ISNI:0000 0004 0624 6108); Equipe labélisée Ligue Contre le Cancer, Paris, France (GRID:grid.488845.d) 
 KU Leuven–University of Leuven, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
 IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Univ Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France (GRID:grid.488845.d) (ISNI:0000 0004 0624 6108) 
 I2MC, Institute of Metabolic and Cardiovascular Diseases, Université de Toulouse, INSERM, Université Toulouse III – Paul Sabatier (UPS), Toulouse, France (GRID:grid.462178.e) (ISNI:0000 0004 0537 1089) 
 KU Leuven–University of Leuven, Department of Cellular and Molecular Medicine, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
 University of Malaga, Department of Surgical Specialties, Biochemistry and Immunology School of Medicine, Malaga, Spain (GRID:grid.10215.37) (ISNI:0000 0001 2298 7828) 
 Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283 - UMR 8199 - EGID, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845) 
 IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Univ Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France (GRID:grid.488845.d) (ISNI:0000 0004 0624 6108); BioCampus, RHEM, Université de Montpellier, CNRS, INSERM, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
 CIBER of Physiopathology, Obesity and Nutrition (CIBEROBN), Málaga, Spain; Unidad de Gestion Clinica de Endocrinologia y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clinico Virgen de la Victoria, Málaga, Spain (GRID:grid.452525.1) 
10  I2MC, Institute of Metabolic and Cardiovascular Diseases, Université de Toulouse, INSERM, Université Toulouse III – Paul Sabatier (UPS), Toulouse, France (GRID:grid.462178.e) (ISNI:0000 0004 0537 1089); Toulouse University Hospitals, Department of Clinical Biochemistry, Toulouse, France (GRID:grid.508721.9) 
11  Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2605422237
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.